ADVERSE REACTIONS TO PLASMA-VOLUME EXPANDERS

被引：12

作者：

FISHER, MM

BRADY, PW

机构：

[1] Intensive Therapy Unit, Department of Cardiothoracic Surgery, Royal North Shore Hospital of Sydney, St Leonards, New South Wales

来源：

DRUG SAFETY | 1990年 / 5卷 / 02期

关键词：

D O I：

10.2165/00002018-199005020-00002

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Plasma volume expanders are effective in the restoration of blood volume. All the available plasma volume expanders may rarely induce anaphylactoid reactions, although such reactions are extremely uncommon in shocked patients. The reactions are caused by different mechanisms depending on the solution, and there is little evidence that IgE antibodies are involved. In addition to these reactions, effects on haemostasis and renal function may occur, and the persistence of hydroxyethyl starch in the body has led to concern about its potential role as a carcinogen, although there is no evidence to suggest that this has occurred. © 1990, ADIS Press Limited. All rights reserved.

引用

页码：86 / 93

页数：8

共 42 条

[1]

Adlmann B., Schoning B., Binding of native and denatured collagen to immunoglobulins and cold insoluble globulin (CIG) in serum of patients undergoing orthopaedic surgery, Klinische Wochenschrift, 58, pp. 625-629, (1980)

[2]

Alexander B., Effects of plasma expanders on coagulation and haemostasis: dextran, hydroxyethyl starch, and other macro-molecules revisited

[3]

blood colloids and plasma expanders, Progress in Clinical and Biological Research, 19, pp. 292-298, (1978)

[4]

Annest S.J., Scoulli W.A., Blumenstock F.A., Stratton H.H., Newell J.C., Et al., Increased creatinine clearance following cryoprecipitate infusion in trauma and surgical patients with decreased renal function, Journal of Trauma, 20, pp. 726-730, (1980)

[5]

Bernstein R.L., Rosenberg A.D., Pada E.Y., Jaffe F.F., A severe reaction to dextran despite hapten inhibition, Anaesthesiology, 67, pp. 567-569, (1987)

[6]

Biro G.P., Fluorocarbons in resuscitation of haemorrhage, International Anaesthesiology Clinics, 23, pp. 143-168, (1985)

[7]

Bland J.H.L., Laver M.B., Lowenstein E., Vasodilator effect of commercial 5% plasma protein solutions, Journal of the American Medical Association, 224, pp. 1721-1723, (1973)

[8]

Boon J.C., Jesch F., Ring J., Messmer K., Long term intravascular persistence of hydroxyethyl starch (HES) in man, European Surgical Research, 8, pp. 497-503, (1976)

[9]

Claggett G.P., Reisch J.S., Prevention of venous thromboembolism in general surgical patients: results of meta-analysis, Annals of Surgery, 208, pp. 227-240, (1988)

[10]

Coghill T.H., Moore E.E., Dunn E.L., Cohen R.G., Coagulation changes after albumin resuscitation, Critical Care Medicine, 9, pp. 22-26, (1981)

← 1 2 3 4 5 →